冠動脈ステントの世界市場 (2023-2030年)：製品タイプ (ベアメタルステント (BMS)・薬剤溶出ステント (DES))・生体材料 (生体材料・高分子生体材料) 別の規模・シェア・成長分析・予測

世界の冠動脈ステントの市場規模は、2021年の88億米ドルから、2022年の90億9,000万米ドルから、予測期間中は3.3%のCAGRで推移し、2030年には117億9,000万米ドルの規模に成長すると予測されています。

世界の冠動脈ステントの市場は近年、著しい成長と進歩を遂げています。市場成長の主な要因は、心血管疾患の有病率の増加、高齢者人口の増加、低侵襲手技の採用拡大などです。冠動脈疾患を含む心血管疾患の増加が冠動脈ステントに対する需要の高まりにつながっています。ライフスタイルの変化、座りがちな生活習慣、不健康な食生活などがこれらの疾患の発生率の増加に寄与しています。さらに、高齢者は心血管系疾患にかかりやすく、冠動脈ステントの需要をさらに高めています。

ステント設計における技術の進歩と革新は、患者の転帰と安全性を大幅に改善しました。薬剤溶出ステント (DES) と生体吸収性ステントの開発により、再狭窄のリスクが減少し、長期成績が改善しました。こうした進歩により、従来のベアメタルステントから薬剤溶出性ステントや生体吸収性ステントへの移行が進み、市場成長を牽引しています。

一方で、市場は一定の課題にも直面しています。主な課題の1つは、ステント自体の費用や植え込み手術など、冠動脈ステント処置に関連する費用が高いことです。このため、低所得地域や経済的に余裕のない患者によるステントの導入が制限される可能性があります。

当レポートでは、世界の冠動脈ステントの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

• エグゼクティブサマリー
• 調査手法
• 親市場の分析
  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
• 主要な市場洞察
  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資分析
  • 主要な成功要因
  • 競合の程度
  • 市場力学と見通し
    • 市場力学
      • 促進要因
      • 機会
      • 抑制要因
      • 課題
  • 規制状況
  • ポーターの分析
  • 将来のディスラプションに関するSkyquestの特別な洞察
• 世界の冠動脈ステント市場：製品タイプ別
  • ベアメタルステント (BMS)
  • 薬剤溶出ステント (DES)
  • 生体吸収性スキャフォールド (BVS)
• 世界の冠動脈ステント市場：生体材料別
  • 市場概要
  • 生体材料
  • 高分子生体材料
  • 天然生体材料
• 世界の冠動脈ステント市場：地域別
  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 競合情勢
  • トップ5社の比較
  • 主要企業の市場での位置付け
  • 主要企業の採用戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア
• 主要企業プロファイル
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Cook Medical Inc.
  • C. R. Bard, Inc.
  • Biosensors International Group, Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • Stentys SA
  • Hexacath
  • Translumina GmbH
  • Elixir Medical Corporation
  • Vascular Concepts
  • Alvimedica
  • InspireMD Inc.
  • Comed B.V.

Global Coronary Stent Market size was valued at USD 8.8 Billion in 2021 and is poised to grow from USD 9.09 Billion in 2022 to USD 11.79 Billion by 2030, at a CAGR of 3.3% during the forecast period (2023-2030).

The global coronary stent market has witnessed significant growth and advancements in recent years. The market growth is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. The rise in cardiovascular diseases, including coronary artery disease, has led to a higher demand for coronary stents. Lifestyle changes, sedentary habits, and unhealthy diets contribute to the increasing incidence of these diseases worldwide. Additionally, the aging population is more susceptible to cardiovascular conditions, further fueling the demand for coronary stents. Technological advancements and innovations in stent designs have significantly improved patient outcomes and safety. The development of drug-eluting stents (DES) and bioresorbable stents has reduced the risk of restenosis and improved long-term results. These advancements have led to a shift from traditional bare-metal stents to drug-eluting and bioresorbable stents, driving market growth. However, the coronary stent market faces certain challenges. One of the major challenges is the high cost associated with coronary stent procedures, including the cost of stents themselves and the implantation procedure. This can limit the adoption of stents in lower-income regions or by patients with limited financial resources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Coronary Stent Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Stent Market Segmental Analysis

The global coronary stent market is segmented on the basis of product, biomaterial, and region. By product, the market is segmented into Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS). By biomaterial, the market is segmented into Biomaterials, Polymeric Biomaterials, and Natural Biomaterials. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Coronary Stent Market Dynamics

Drivers of the Global Coronary Stent Market

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Growing Aging Population

The aging population is more susceptible to cardiovascular conditions, leading to a higher demand for coronary stents. As the global population continues to age, the prevalence of cardiovascular diseases is expected to increase, driving the demand for coronary stents.

Restraints in the Global Coronary Stent Market

Stringent Regulatory Approval Processes

The stringent regulatory approval processes imposed by regulatory authorities can pose challenges for market growth. Manufacturers must comply with safety and efficacy assessments, which can be time-consuming and resource-intensive, delaying the market entry of new products.

Potential Complications

Stent implantation carries certain risks and potential complications, such as stent thrombosis, restenosis, and allergic reactions. These complications may affect patient outcomes and increase concerns among healthcare providers and patients, impacting market growth.

Market Trends of the Global Coronary Stent Key

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

Rising Focus on Patient-Specific Stenting: Personalized medicine and the concept of patient-specific stenting are gaining attention. Advanced imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are used to assess the morphology and dimensions of coronary arteries, allowing for customized stent selection and placement.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Coronary Stent Market by Product Type
  • Market Overview
  • Bare Metal Stents (BMS)
  • Drug-Eluting Stents (DES)
  • and Bioresorbable Vascular Scaffold (BVS)
• Global Coronary Stent Market by Biomaterial
  • Market Overview
  • Biomaterials
  • Polymeric Biomaterials
  • and Natural Biomaterials
• Global Coronary Stent Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Abbott Laboratories (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Terumo Corporation (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • B. Braun Melsungen AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cook Medical Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • C. R. Bard, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biosensors International Group, Ltd. (Singapore)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Meril Life Sciences Pvt. Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MicroPort Scientific Corporation (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biotronik SE & Co. KG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Stentys SA (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Hexacath (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Translumina GmbH (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Elixir Medical Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Vascular Concepts (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Alvimedica (Turkey)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • InspireMD Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Comed B.V. (Netherlands)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments